BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26068144)

  • 1. Paeoniflorin Atttenuates Amyloidogenesis and the Inflammatory Responses in a Transgenic Mouse Model of Alzheimer's Disease.
    Zhang HR; Peng JH; Cheng XB; Shi BZ; Zhang MY; Xu RX
    Neurochem Res; 2015 Aug; 40(8):1583-92. PubMed ID: 26068144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide Rescues Spatial Memory Deficits and Amyloid-β Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.
    Cui YQ; Wang Q; Zhang DM; Wang JY; Xiao B; Zheng Y; Wang XM
    Curr Alzheimer Res; 2016; 13(3):288-96. PubMed ID: 26906357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer's disease.
    Kong F; Jiang X; Wang R; Zhai S; Zhang Y; Wang D
    J Neuroinflammation; 2020 Oct; 17(1):305. PubMed ID: 33059746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling pathway in APP/PS1 mice.
    Zhou Z; Hou J; Mo Y; Ren M; Yang G; Qu Z; Hu Y
    Eur J Pharmacol; 2020 Feb; 869():172857. PubMed ID: 31837991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
    Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX
    Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
    Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
    Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
    Toledo EM; Inestrosa NC
    Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease.
    Couturier J; Stancu IC; Schakman O; Pierrot N; Huaux F; Kienlen-Campard P; Dewachter I; Octave JN
    J Neuroinflammation; 2016 Jan; 13():20. PubMed ID: 26818951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model.
    Park TS; Ryu YK; Park HY; Kim JY; Go J; Noh JR; Kim YH; Hwang JH; Choi DH; Oh WK; Lee CH; Kim KS
    Int J Mol Med; 2017 Jan; 39(1):21-30. PubMed ID: 28004107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiacremonone Potentiates Anti-Oxidant Effects to Improve Memory Dysfunction in an APP/PS1 Transgenic Mice Model.
    Yun HM; Jin P; Park KR; Hwang J; Jeong HS; Kim EC; Jung JK; Oh KW; Hwang BY; Han SB; Hong JT
    Mol Neurobiol; 2016 May; 53(4):2409-20. PubMed ID: 26008621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice.
    Ou Z; Kong X; Sun X; He X; Zhang L; Gong Z; Huang J; Xu B; Long D; Li J; Li Q; Xu L; Xuan A
    Brain Behav Immun; 2018 Mar; 69():351-363. PubMed ID: 29253574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of tormentic acid against memory impairment and neuro‑inflammation in an Alzheimer's disease mouse model.
    Cui W; Sun C; Ma Y; Wang S; Wang X; Zhang Y
    Mol Med Rep; 2020 Aug; 22(2):739-750. PubMed ID: 32468017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect and mechanism of traditional Chinese herbs against Aβ expression in brain tissues of mice with Alzheimer's disease].
    Zhou NN; Zhu R; Zhao XM; Liang P
    Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):780-785. PubMed ID: 27821233
    [No Abstract]   [Full Text] [Related]  

  • 17. Quetiapine attenuates glial activation and proinflammatory cytokines in APP/PS1 transgenic mice via inhibition of nuclear factor-κB pathway.
    Zhu S; Shi R; Li V; Wang J; Zhang R; Tempier A; He J; Kong J; Wang JF; Li XM
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25618401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
    Duffy AM; Hölscher C
    Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RP1, a RAGE antagonist peptide, can improve memory impairment and reduce Aβ plaque load in the APP/PS1 mouse model of Alzheimer's disease.
    Huang YY; Fang N; Luo HR; Gao F; Zou Y; Zhou LL; Zeng QP; Fang SS; Xiao F; Zheng Q
    Neuropharmacology; 2020 Dec; 180():108304. PubMed ID: 32931813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation.
    Guo HB; Cheng YF; Wu JG; Wang CM; Wang HT; Zhang C; Qiu ZK; Xu JP
    Neuroscience; 2015 Apr; 290():530-42. PubMed ID: 25662507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.